Bio-Gene Technology Limited (BGT.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -3.06 Million AUD | 3.76% |
| 2023 | -3.18 Million AUD | -7.01% |
| 2022 | -2.97 Million AUD | -20.61% |
| 2021 | -2.46 Million AUD | -14.09% |
| 2020 | -2.16 Million AUD | 1.39% |
| 2019 | -2.19 Million AUD | 33.61% |
| 2018 | -3.3 Million AUD | -185.71% |
| 2017 | -1.15 Million AUD | -127.01% |
| 2016 | -508.93 Thousand AUD | -184.79% |
| 2015 | -178.7 Thousand AUD | -29.99% |
| 2014 | -137.46 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.33 Million AUD | 0.0% |
| 2024 FY | -3.1 Million AUD | 2.55% |
| 2024 Q4 | -1.72 Million AUD | 0.0% |
| 2023 Q2 | -2.06 Million AUD | 0.0% |
| 2023 FY | -3.18 Million AUD | -7.01% |
| 2023 Q4 | -1.56 Million AUD | 0.0% |
| 2022 Q2 | -1.49 Million AUD | 0.0% |
| 2022 FY | -2.97 Million AUD | -20.61% |
| 2022 Q4 | -1.9 Million AUD | 0.0% |
| 2021 Q4 | -1.59 Million AUD | 0.0% |
| 2021 Q1 | -483.27 Thousand AUD | 64.92% |
| 2021 FY | -2.46 Million AUD | -14.09% |
| 2021 Q2 | -1.37 Million AUD | -185.29% |
| 2020 Q2 | -1.56 Million AUD | 0.0% |
| 2020 Q4 | -1.37 Million AUD | -185.07% |
| 2020 Q3 | -483.27 Thousand AUD | 69.13% |
| 2020 FY | -2.16 Million AUD | 1.39% |
| 2019 Q3 | -513.89 Thousand AUD | 59.42% |
| 2019 FY | -2.19 Million AUD | 33.61% |
| 2019 Q4 | -1.35 Million AUD | -163.24% |
| 2019 Q2 | -1.26 Million AUD | 0.0% |
| 2018 Q4 | -1.28 Million AUD | -81.25% |
| 2018 FY | -3.3 Million AUD | -185.71% |
| 2018 Q2 | -1.24 Million AUD | 0.0% |
| 2018 Q3 | -708.26 Thousand AUD | 43.33% |
| 2017 Q4 | -740.82 Thousand AUD | 0.0% |
| 2017 FY | -1.15 Million AUD | -127.01% |
| 2017 Q2 | -314.07 Thousand AUD | 0.0% |
| 2016 FY | -508.93 Thousand AUD | -184.79% |
| 2015 FY | -178.7 Thousand AUD | -29.99% |
| 2014 FY | -137.46 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 41.796% |
| Acrux Limited | -9.83 Million AUD | 68.858% |
| Race Oncology Limited | -13.38 Million AUD | 77.113% |
| Biome Australia Limited | -1.91 Million AUD | -60.067% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 79.167% |
| BTC Health Limited | 1.05 Million AUD | 390.202% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 75.121% |
| CSL Limited | 5.64 Billion AUD | 100.054% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 93.164% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 106.231% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 131.518% |
| Hexima Limited | -1 Million AUD | -203.59% |
| Immutep Limited | -44.93 Million AUD | 93.185% |
| Memphasys Limited | -2.7 Million AUD | -13.257% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 101.355% |
| Noxopharm Limited | -7.53 Million AUD | 59.357% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 57.385% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 93.513% |
| Starpharma Holdings Limited | -15.15 Million AUD | 79.798% |
| Tissue Repair Ltd | -4.87 Million AUD | 37.192% |
| Biotron Limited | -5.15 Million AUD | 40.548% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 84.377% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -109.883% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 48.428% |
| Patrys Limited | -3.53 Million AUD | 13.469% |
| Orthocell Limited | -11.68 Million AUD | 73.783% |
| Imugene Limited | -140.93 Million AUD | 97.827% |
| PYC Therapeutics Limited | -38.85 Million AUD | 92.119% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 57.651% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 65.231% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 57.425% |
| Nanollose Limited | -1.24 Million AUD | -145.031% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -43.533% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -48.912% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 30.791% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -6.566% |
| Nyrada Inc. | -4.56 Million AUD | 32.846% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 87.779% |
| PharmAust Limited | -6.65 Million AUD | 54.008% |
| AnteoTech Limited | -11.72 Million AUD | 73.884% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 95.297% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 86.112% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 33.268% |
| Actinogen Medical Limited | -12.83 Million AUD | 76.147% |
| Immuron Limited | -5.8 Million AUD | 47.209% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 46.0% |